AAV Bioreactor scale-up bench-marking survey Dec 2022 | Benchmarking, Cell & Gene Therapy, Commercialization, Deliverable, Deliverables ReportA BioPhorum member only survey to help gain further insight around how the industry is approaching scaling the production of AAV in suspension HEK- 293 cells from lab to commercial scale. read more
